Get the Stockscreener App
30.52
0.10%
0.0318
Pre-market:
30.43
-0.0852
-0.28%
Roundhill Glp 1 Weight Loss Etf stock is traded at $30.52, with a volume of 9,570.
It is up +0.10% in the last 24 hours and down -1.09% over the past month.
See More
Previous Close:
$30.48
Open:
$30.71
24h Volume:
9,570
Relative Volume:
0.46
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+2.10%
1M Performance:
-1.09%
6M Performance:
-9.02%
1Y Performance:
+18.55%
1-Day Range:
$30.52
$30.98
1-Week Range:
$29.81
$30.98
52-Week Range:
$23.22
$37.15
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Company Profile
Name
Roundhill Glp 1 Weight Loss Etf
Sector
Industry
Phone
-
Address
-
Compare OZEM vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OZEM
Roundhill Glp 1 Weight Loss Etf
|
30.52 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
365.76 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
740.96 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
742.61 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
293.07 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
722.51 | 124.43B | 0 | 0 | 0 | 0.00 |
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Latest News
Healthcare ETFs: From Broad Exposure to Big Breakthroughs - ETF Trends
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market - The Globe and Mail
TD Cowen Raises GLP-1 Sales Forecast To $150B By 2030 – Industry Leaders LLY, NVO To Remain Dominant - TradingView
GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain - The Globe and Mail
485BPOS: Post-effective amendment - Moomoo
3 Ways to Invest in the Growing GLP-1 Weight Loss Market - MarketBeat
Stock List: Research Stocks from Around the World - GuruFocus
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
OZEM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
OZEM Stock Price, News & Analysis - Stock Titan
Can You Buy Ozempic Stock in 2026? - The Motley Fool
FDA Approves NVO's Increased Wegovy Dosage: Broaden Your Portfolio With These Healthcare ETFs - Bitget
FDA Clears NVO's Higher Dose of Wegovy: Diversify With These Health ETFs - The Globe and Mail
Discipline and Rules-Based Execution in OZEM Response - Stock Traders Daily
Here are the quant ratings of OZEM’s top holdings amid Novo's selloff - MSN
OZEM stock: What the Ratings say (OZEM:NASDAQ) - Seeking Alpha
ETFs with Pfizer Inc. ( PFE ) Exposure - ETF Database
Behavioral Patterns of OZEM and Institutional Flows - Stock Traders Daily
Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Short Interest Up 47.1% in January - Defense World
How to Invest in GLP-1 Stocks in 2026 - The Motley Fool
(OZEM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook - The Globe and Mail
NVO Receives FDA Approval for MASH Therapy: ETFs Expected to Benefit - intellectia.ai
OZEM Vs. THNR: Which Is The Better ETF In The GLP-1 And Weight Loss Space? - Seeking Alpha
EXCLUSIVE: Trump 'Amplified' Several Investing Themes – ETF CEO Picks 3 Sectors Benefitting The Most - Benzinga
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All - MarketBeat
New Year, New Strategy: Navigating Weight Loss ETFs - ETF Database
Insiders Bullish on Certain Holdings of OZEM - Nasdaq
How Roundhill Etf Trust Glp-1 & Weight Loss Etf (OZEM) Affects Rotational Strategy Timing - Stock Traders Daily
The Obesity Pill Rush: Healthcare ETFs to Gain as FDA Nods to Novo Drug - The Globe and Mail
6 Top-Performing ETF Areas of Last Week - sharewise.com
(OZEM) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Best-Performing ETFs of November - TradingView — Track All Markets
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in - TradingView
Eli Lilly Leads $150B Obesity Drug Race As Novo, Pfizer Battle; ETFs Poised To GainAbbVie (NYSE:ABBV) - Benzinga
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Financials Data
There is no financial data for Roundhill Glp 1 Weight Loss Etf (OZEM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.89%
Cap:
|
Volume (24h):